摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S,3R)-2-amino-4-chloro-1-phenylbutan-3-ol | 160233-25-0

中文名称
——
中文别名
——
英文名称
(2S,3R)-2-amino-4-chloro-1-phenylbutan-3-ol
英文别名
(2R,3S)-3-amino-1-chloro-4-phenylbutan-2-ol
(2S,3R)-2-amino-4-chloro-1-phenylbutan-3-ol化学式
CAS
160233-25-0
化学式
C10H14ClNO
mdl
——
分子量
199.68
InChiKey
YXWOYBQZWSLSMU-UWVGGRQHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    13
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    46.2
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • Production method of aminochlorohydrin sulfate
    申请人:Ajinomoto Co., Inc.
    公开号:EP1777213A1
    公开(公告)日:2007-04-25
    Highly pure (2R,3S)-3-tert-butoxycarbonylamino-1-chloro-2-hydroxy-4-phenylbutane or (2S,3R)-3-tert-butoxycarbonylamino-1-chloro-2-hydroxy-4-phenylbutane may be conveniently produced in high yield by: (a) reacting compound (1) with lithiumchloromethane to give compound (2) and at least a byproduct; (b) dissolving compound (2) and the byproduct in a polar solvent and adding water to the solution to precipitate compound (2) as crystals; (c) reducing the crystals of compound (2) to give compound (3) and at least its diastereomer as an impurity; (d) adding sulfuric acid thereto to give compound (4) and at least its diastereomer as an impurity; and (e) precipitating compound (4) as crystals from a solution containing acetic acid ester or acetic acid ester.
    (2R,3S)-3-tert-butoxycarbonylamino-1-chloro-2-hydroxy-4-phenylbutane或(2S,3R)-3-tert-butoxycarbonylamino-1-chloro-2-hydroxy-4-phenylbutane可以通过以下步骤方便地高产率地制备:(a)将化合物(1)与氯甲基锂反应,得到化合物(2)和至少一种副产物;(b)将化合物(2)和副产物溶解在极性溶剂中,并向溶液中加入水,使化合物(2)以晶体形式沉淀出来;(c)将化合物(2)的晶体还原,得到化合物(3)和至少其对映异构体作为杂质;(d)加入硫酸至其中,得到化合物(4)和至少其对映异构体作为杂质;(e)从含有乙酸酯或乙酸酯的溶液中沉淀化合物(4)为晶体。
  • [EN] PROCESS FOR PREPARATION OF ATAZANAVIR OR ITS BISULFATE SALT<br/>[FR] PROCÉDÉ DE PRÉPARATION D'ATAZANAVIR OU DE SON SEL BISULFATE
    申请人:RANBAXY LAB LTD
    公开号:WO2013014633A1
    公开(公告)日:2013-01-31
    The present invention relates to an improved process for the preparation of atazanavir bisulfate, an inhibitor of retroviral aspartate protease. The process of the present invention comprises conversion of 1,1-dimethylethyl[(2S,3R)-4-chloro-3-hydroxy- -phenylbutan-2-yl]carbamate (Formula II) into 1-[4-(pyridine-2-yl)-phenyl]-4(S)-5 hydroxy-2-N-tert-butoxycarbonylamino-5(S)-N-(N-methoxycarbonyl-(L)-tert- leucyl)amino-6-phenyl-2-azahexane (Formula VII) without isolating intermediate compounds formed therein, followed by its subsequent conversion to atazanavir or its bisulfate salt.
    本发明涉及一种改进的制备阿扎那韦硫酸盐的方法,阿扎那韦是一种逆转录病毒天冬氨酸蛋白酶抑制剂。本发明的方法包括将1,1-二甲基乙基[(2S,3R)-4-氯-3-羟基苯丁基]氨基甲酸酯(式II)转化为1-[4-(吡啶-2-基)-苯基]-4(S)-5-羟基-2-N-叔丁氧羰基氨基-5(S)-N-(N-甲氧羰基-(L)-叔亮氨酰)氨基-6-苯基-2-氮杂己烷(式VII),而不需要分离其中形成的中间化合物,然后将其进一步转化为阿扎那韦或其硫酸盐。
  • [EN] REDUCTION OF ALDEHYDES AND KETONES TO ALCOHOLS<br/>[FR] RÉDUCTION D'ALDÉHYDES ET DE CÉTONES EN ALCOOLS
    申请人:AMERICAN PACIFIC CORP
    公开号:WO2011060302A1
    公开(公告)日:2011-05-19
    The embodiments described herein provide a reduction of an aldehyde or a ketone, such as a Meerwein-Ponnorf-Verley (MPV) reaction of an aldehyde or ketone. In some embodiments, the reaction occurs in the presence of A1[OC(CH3)3]. In some embodiments, the reaction occurs in the presence of an aprotic solvent. In some embodiments, the aldehyde or ketone is an amino aldehyde or an amino ketone wherein the amine is group is protected such that the nitrogen of the amine has no proton. Other embodiments related to compositions and compounds related to the reduction reaction, or to the preparation or use of the aldehyde, the ketone, or the resulting alcohol.
    本文所述实施例提供了醛或酮的还原,例如醛或酮的Meerwein-Ponnorf-Verley(MPV)反应。在某些实施例中,反应发生在A1 [OC(CH3)3]的存在下。在某些实施例中,反应发生在无极溶剂的存在下。在某些实施例中,醛或酮是氨基醛或氨基酮,其中氨基团被保护,使得氨基的氮没有质子。其他实施例涉及与还原反应相关的组合物和化合物,或与醛、酮或所得醇的制备或使用相关的实施例。
  • PROCESS FOR THE PREPARATION OF 3,4-EPOXY-2-AMINO-1-SUBSTITUTED BUTANE DERIVATIVES AND INTERMEDIATE COMPOUNDS THEREOF
    申请人:Singh Rakesh
    公开号:US20110178305A1
    公开(公告)日:2011-07-21
    The present invention relates to a process for the preparation of threo-3,4-epoxy-2-amino-1-substituted butane derivatives represented by general Formula I which comprises reacting compound of Formula III or salt thereof with an active ester of acid of Formula IV and treating the product thereof with base. The carbon atom bonded to the radical R 3 in Formula I and IV is in the (R)-, (S)- or (R,S)-configuration. The compounds of Formula I and III, particularly in their (2S,3R) configuration are useful intermediates for the preparation of atazanavir bisulfate.
    本发明涉及一种制备一般式I所表示的threo-3,4-环氧-2-氨基-1-取代丁烷衍生物的过程,该过程包括将一般式III化合物或其盐与一般式IV的酸的活性酯反应,然后用碱处理其产物。在公式I和IV中与基团R3键合的碳原子处于(R)-、(S)-或(R,S)-构型。一般式I和III的化合物,特别是它们的(2S,3R)构型,是制备阿扎那韦双硫酸盐的有用中间体。
  • KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS
    申请人:Bong Yong Koy
    公开号:US20120190086A1
    公开(公告)日:2012-07-26
    The present disclosure relates to engineered ketoreductase polypeptides and uses thereof for the preparation of α chloroalcohols from α chloroketones. Also provided are polynucleotides encoding the engineered ketoreductase polypeptides and host cells capable of expressing the engineered ketoreductase polypeptides.
    本公开涉及工程化的酮还原酶多肽及其在制备α-氯代醇中的应用。还提供了编码工程酮还原酶多肽的多核苷酸和能够表达工程酮还原酶多肽的宿主细胞。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐